ESR1 and metastatic malignant neoplasm in the lymph nodes: Hao et al. showed increased expression of IGFBP5 in lymph node metastases of breast carcinoma [57] and Li et al. demonstrated association between increased transcript levels of IGFBP5 and axillary lymph node metastasis and estrogen receptor expression in breast tumors [62].